Clinical Evaluation of MyoCare in Europe (CEME) (CEME)
Clinical Evaluation of MyoCare in Europe (CEME): Study Protocol for a Prospective, Multicenter, Randomized, Double-blinded, and Controlled Clinical Trial.
Sponsor: CPO Clinica Privada de Oftalmologia, S.A.
This NA trial investigates Myopia, Progressive and is currently ongoing. CPO Clinica Privada de Oftalmologia, S.A. leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Nov 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jul 2023 — Nov 2023 [monthly]
Recruiting NA
First recorded
Sep 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CPO Clinica Privada de Oftalmologia, S.A.
- Carl Zeiss Vision International GmbH
- Cooperativa de Ensino Superior, Politécnico e Universitário
- ICQO Instituto Quirúrgico de Oftalmología
- Instituto de Cirugia Ocular
- Miranza Virgen de Lujan
- Novovision
- Universidad Complutense de Madrid
For direct contact, visit the study record on ClinicalTrials.gov .